Department of Chemistry, Penn State University, University Park, PA 16802, United States of America.
The Huck Institutes of the Life Sciences, Penn State University, University Park, PA 16802, United States of America.
Biofabrication. 2023 Apr 4;15(3):035001. doi: 10.1088/1758-5090/acc4eb.
Microgels have recently received widespread attention for their applications in a wide array of domains such as tissue engineering, regenerative medicine, and cell and tissue transplantation because of their properties like injectability, modularity, porosity, and the ability to be customized in terms of size, form, and mechanical properties. However, it is still challenging to mass (high-throughput) produce microgels with diverse sizes and tunable properties. Herein, we utilized an air-assisted co-axial device (ACAD) for continuous production of microgels in a high-throughput manner. To test its robustness, microgels of multiple hydrogels and their combination, including alginate (Alg), gelatin methacrylate (GelMA) and Alg-GelMA, were formed at a maximum production rate of ∼65 000 microgels swhile retaining circularity and a size range of 50-500m based on varying air pressure levels. The ACAD platform allowed single and multiple cell encapsulation with 74 ± 6% efficiency. These microgels illustrated appealing rheological properties such as yield stress, viscosity, and shear modulus for bioprinting applications. Specifically, Alg microgels have the potential to be used as a sacrificial support bath while GelMA microgels have potential for direct extrusion both on their own or when loaded in a bulk GelMA hydrogel. Generated microgels showed high cell viability (>90%) and proliferation of MDA-MB-231 and human dermal fibroblasts over seven days in both encapsulation and scaffolding applications, particularly for GelMA microgels. The developed strategy provides a facile and rapid approach without any complex or expensive consumables and accessories for scalable high-throughput microgel production for cell therapy, tissue regeneration and 3D bioprinting applications.
微凝胶因其可注射性、模块性、多孔性和可根据尺寸、形状和机械性能进行定制的能力等特性,在组织工程、再生医学以及细胞和组织移植等广泛领域得到了广泛关注。然而,仍然难以大规模(高通量)生产具有不同尺寸和可调特性的微凝胶。在此,我们利用空气辅助同轴装置(ACAD)以高通量方式连续生产微凝胶。为了测试其稳健性,我们以最大生产速度∼65000 微凝胶 s-1 形成了多种水凝胶及其组合的微凝胶,包括海藻酸盐(Alg)、甲基丙烯酰化明胶(GelMA)和 Alg-GelMA,同时基于不同的气压水平保持了圆形和 50-500μm 的尺寸范围。ACAD 平台允许单和多细胞封装,效率为 74±6%。这些微凝胶展示了有吸引力的流变学特性,如用于生物打印应用的屈服应力、粘度和剪切模量。具体来说,Alg 微凝胶具有作为牺牲支撑浴的潜力,而 GelMA 微凝胶具有自身直接挤出的潜力,或者在块状 GelMA 水凝胶中加载时也具有这种潜力。在封装和支架应用中,生成的微凝胶在七天内显示出高细胞活力(>90%)和 MDA-MB-231 和人真皮成纤维细胞的增殖,特别是对于 GelMA 微凝胶。所开发的策略提供了一种简单、快速的方法,无需任何复杂或昂贵的耗材和配件,可用于细胞治疗、组织再生和 3D 生物打印应用的可扩展高通量微凝胶生产。